Study to Evaluate the Feasibility of Community-based Test and Treat Strategies Among Men Who Have Sex With Men and Transgender Women to Increase the Uptake of HIV Testing and Treatment Services in Thailand

Thai Red Cross AIDS Research Centre (TRC-ARC)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02383602

Enrollment

6000

Registered

2015-03-09

Start date

2014-08-15

Completion date

2023-02-16

Last updated

2023-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Test and Treat

Keywords

6,000 Thai MSM and TG from study sites in Bangkok, Chiang Mai, Chonburi and Songkhla

Brief summary

HIV counseling and testing, risk reduction counseling, provision of condoms and lubricants Same-day result HIV testing along with pre-test and post-test counseling, including risk reduction counseling, will be provided according to the standard practice at each study site at enrollment and every 6 months in HIV-negative participants. HIV-negative participants can also access non-occupational post-exposure prophylaxis service and symptomatic STD service if these are available at study sites. HIV-positive participants will also receive risk reduction counseling every 3 months. Condoms and lubricants will be provided free of charge.

Detailed description

This study is a prospective observational cohort study that will enroll up to 6,000 Thai MSM and TG from drop-in centers in Bangkok, Chiang Mai, Chonburi and Songkhla. Each participant will have HIV testing at baseline and will be followed up for 18 months. HIV-negative participants will be asked to have HIV re-testing every 6 months. HIV-positive participants will have POC CD4 testing and ART initiation regardless of CD4 count will be offered. Those who accept ART will be followed up at week 2, week 4, month 2, month 3 and every 3 months thereafter. Those who deny ART will be followed up every 3 months. Uptake of HIV re-testing will be determined. Access to POC CD4 testing and acceptability of ART initiated at HIV diagnosis regardless of CD4 count along with ART adherence will also be determined.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

1. Thai national 2. Age \>18 years 3. Men or transgender women who report unprotected anal intercourse with a man at least one time in the past 6 months 4. Not known to be HIV-positive, i.e., never tested for HIV or previous HIV test(s) negative 5. Willing to participate in the study 6. Provide written informed consent

Exclusion criteria

1\. Known HIV-positive serostatus

Design outcomes

Primary

Measure	Time frame	Description
To determine the uptake of HIV testing among MSM and TG as a result of the community-based Test and Treat approach	36 months	1. Increase in the number of individuals tested who have not previously had an HIV test 2. Increase in the number of HIV-positive individuals tested who did not previously know their HIV status 3. Increase in the proportion of HIV-negative individuals who are retested at least twice a year, every six months

Countries

Thailand

Outcome results